Business Description
Burning Rock Biotech Ltd
ISIN : US12233L1070
Share Class Description:
FRA:6BU0: ADRDescription
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through our in-hospital model and smaller hospitals through our central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 30.14 | |||||
Equity-to-Asset | 0.73 | |||||
Debt-to-Equity | 0.03 | |||||
Debt-to-EBITDA | -0.03 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -5.27 | |||||
Beneish M-Score | -4.59 | |||||
WACC vs ROIC |
Growth Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -8.5 | |||||
3-Year EBITDA Growth Rate | 5.2 | |||||
3-Year EPS without NRI Growth Rate | 5.4 | |||||
3-Year FCF Growth Rate | -2.1 | |||||
3-Year Book Growth Rate | -33.3 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 9.2 | |||||
9-Day RSI | 13.23 | |||||
14-Day RSI | 17.12 | |||||
6-1 Month Momentum % | 6.67 | |||||
12-1 Month Momentum % | -65.07 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.29 | |||||
Quick Ratio | 3.05 | |||||
Cash Ratio | 2.24 | |||||
Days Inventory | 188.14 | |||||
Days Sales Outstanding | 95.04 | |||||
Days Payable | 49.67 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 0.7 | |||||
Shareholder Yield % | 7.91 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 67.26 | |||||
Operating Margin % | -116.48 | |||||
Net Margin % | -113.27 | |||||
FCF Margin % | -35.15 | |||||
ROE % | -66.88 | |||||
ROA % | -49.11 | |||||
ROIC % | -158.8 | |||||
ROC (Joel Greenblatt) % | -305.51 | |||||
ROCE % | -65.36 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 0.95 | |||||
PB Ratio | 0.69 | |||||
Price-to-Tangible-Book | 0.69 | |||||
EV-to-EBIT | 0.1 | |||||
EV-to-EBITDA | 0.1 | |||||
EV-to-Revenue | -0.12 | |||||
EV-to-FCF | 0.33 | |||||
Price-to-Net-Current-Asset-Value | 0.86 | |||||
Price-to-Net-Cash | 1.63 | |||||
Earnings Yield (Greenblatt) % | 1000 | |||||
FCF Yield % | -37.04 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Burning Rock Biotech Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 66.83 | ||
EPS (TTM) (€) | -7.395 | ||
Beta | 0 | ||
Volatility % | 56.9 | ||
14-Day RSI | 17.12 | ||
14-Day ATR (€) | 0.580587 | ||
20-Day SMA (€) | 5.411 | ||
12-1 Month Momentum % | -65.07 | ||
52-Week Range (€) | 2.6 - 22.2 | ||
Shares Outstanding (Mil) | 10.26 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Burning Rock Biotech Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Burning Rock Biotech Ltd Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Burning Rock Biotech Ltd Frequently Asked Questions
What is Burning Rock Biotech Ltd(FRA:6BU0)'s stock price today?
The current price of FRA:6BU0 is €2.60. The 52 week high of FRA:6BU0 is €22.20 and 52 week low is €2.60.
When is next earnings date of Burning Rock Biotech Ltd(FRA:6BU0)?
The next earnings date of Burning Rock Biotech Ltd(FRA:6BU0) is 2024-08-30 Est..
Does Burning Rock Biotech Ltd(FRA:6BU0) pay dividends? If so, how much?
Burning Rock Biotech Ltd(FRA:6BU0) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |